Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α

Abstract

Junction-mediating and regulatory protein (JMY) is a novel p53 cofactor that regulates p53 activity during stress. JMY interacts with p300/CBP, which are ubiquitous transcriptional co-activators that interact with a variety of sequence-specific transcription factors, including hypoxia-inducible factor-1α (HIF-1α). In addition, JMY is an actin-nucleating protein, which, through its WH2 domains, stimulates cell motility. In this study, we show that JMY is upregulated during hypoxia in a HIF-1α-dependent manner. The JMY gene contains HIF-responsive elements in its promoter region and HIF-1α is recruited to its promoter during hypoxia. HIF-1α drives transcription of JMY, which accounts for its induction under hypoxia. Moreover, the enhanced cell motility and invasion that occurs during hypoxia requires JMY, as depleting JMY under hypoxic conditions causes decreased cell motility. Our results establish the interplay between JMY and HIF-1α as a new mechanism that controls cell motility under hypoxic stress.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Biswas S, Troy H, Leek R, Chung YL, Li JL, Raval RR et al. (2010). Effects of HIF-1alpha and HIF-2alpha on growth and metabolism of clear-cell renal cell carcinoma 786-0 xenografts. J Oncol 2010: 757908.

    Article  Google Scholar 

  • Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB . (2001). Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol 3: 667–674.

    Article  CAS  Google Scholar 

  • Coutts AS, Boulahbel H, Graham A, La Thangue NB . (2007). Mdm2 targets the p53 transcription cofactor JMY for degradation. EMBO Rep 8: 84–90.

    Article  CAS  Google Scholar 

  • Coutts AS, Weston L, La Thangue NB . (2009). A transcription co-factor integrates cell adhesion and motility with the p53 response. Proc Natl Acad Sci USA 106: 19872–19877.

    Article  CAS  Google Scholar 

  • Dang DT, Chen F, Gardner LB, Cummins JM, Rago C, Bunz F et al. (2006). Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts. Cancer Res 66: 1684–1936.

    Article  CAS  Google Scholar 

  • Demonacos C, Krstic-Demonacos M, La Thangue NB . (2001). A TPR motif cofactor contributes to p300 activity in the p53 response. Mol Cell 8: 71–84.

    Article  CAS  Google Scholar 

  • Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT et al. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222–1226.

    Article  CAS  Google Scholar 

  • Ferrara N, Hillan KJ, Novotny W . (2005). Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 333: 328–335.

    Article  CAS  Google Scholar 

  • Harris AL . (2002). Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38–47.

    Article  CAS  Google Scholar 

  • Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, Kessler B et al. (2008). Arginine methylation regulates the p53 response. Nat Cell Biol 10: 1431–1439.

    Article  CAS  Google Scholar 

  • Kaelin Jr WG, Ratcliffe PJ . (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30: 393–402.

    Article  CAS  Google Scholar 

  • Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH et al. (2006). Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66: 2725–2731.

    Article  CAS  Google Scholar 

  • Lee K, Lee JH, Boovanahalli SK, Jin Y, Lee M, Jin X et al. (2007). (Aryloxyacetylamino)benzoic acid analogues: a new class of hypoxia-inducible factor-1 inhibitors. J Med Chem 50: 1675–1684.

    Article  CAS  Google Scholar 

  • Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M et al. (2007). Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 67: 11244–11253.

    Article  CAS  Google Scholar 

  • Marine JC, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G . (2006). Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 13: 927–934.

    Article  CAS  Google Scholar 

  • Rankin EB, Giaccia AJ . (2008). The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15: 678–685.

    Article  CAS  Google Scholar 

  • Rapisarda A, Shoemaker RH, Melillo G . (2009). Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads. Cell Cycle 8: 4040–4043.

    Article  CAS  Google Scholar 

  • Semenza GL . (2010). Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29: 625–634.

    Article  CAS  Google Scholar 

  • Shikama N, Lee CW, France S, Delavaine L, Lyon J, Krstic-Demonacos M et al. (1999). A novel cofactor for p300 that regulates the p53 response. Mol Cell 4: 365–376.

    Article  CAS  Google Scholar 

  • Spinella F, Rosano L, Di Castro V, Decandia S, Nicotra MR, Natali PG et al. (2007). Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells. Cancer Res 67: 1725–1734.

    Article  CAS  Google Scholar 

  • Sullivan R, Graham CH . (2007). Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26: 319–331.

    Article  CAS  Google Scholar 

  • Wang GL, Jiang BH, Rue EA, Semenza GL . (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510–5514.

    Article  CAS  Google Scholar 

  • Wang GL, Semenza GL . (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82: 3610–3615.

    CAS  Google Scholar 

  • Zalmas LP, Zhao X, Graham AL, Fisher R, Reilly C, Coutts AS et al. (2008). DNA-damage response control of E2F7 and E2F8. EMBO Rep 9: 252–259.

    Article  Google Scholar 

  • Zuchero JB, Coutts AS, Quinlan ME, La Thangue NB, Mullins RD . (2009). p53-cofactor JMY is a multifunctional actin nucleation factor. Nat Cell Biol 11: 451–459.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the MRC, CRUK, LRF and AICR for support. ASC and LW are funded by MRC and CRUK (grant # C300/6731). IMP and EMH are funded by CRUK (grant # C6415/A9321). We also thank Long Dang, Peter Ratcliffe and Shoumo Bhattacharya for providing invaluable reagents.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N B La Thangue.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coutts, A., Pires, I., Weston, L. et al. Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α. Oncogene 30, 4835–4842 (2011). https://doi.org/10.1038/onc.2011.188

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2011.188

Keywords

This article is cited by

Search

Quick links